期刊文献+

Fas及FasL在大鼠肝癌促癌过程中的表达及作用

The expression and effect of Fas and FasL in rat liver tumor promotion by phenobarbital
下载PDF
导出
摘要 目的 :研究Fas及FasL在实验性大鼠肝促癌过程中的表达及作用。方法 :复制大鼠肝癌启动 /促进模型 ,用免疫组化方法检测大鼠肝促癌过程中Fas及FasL蛋白表达情况。结果 :正常组大鼠肝细胞Fas呈弱阳性表达 ,经启动处理后的各组 (高、中、低剂量组和启动组 )Fas表达增强 ,高、中剂量组在给予促癌物PB后 1周~ 1 5周 ,Fas呈强阳性表达 ,在给予PB1 5周后 ,Fas表达明显呈下降趋势 ,其余各组Fas表达未见明显改变。正常组和促癌组未见FasL蛋白表达 ,其余各组可见Fas表达。高剂量组和中剂量组在加促癌物PB后 1 5周 ,FasL蛋白表达明显增多。结论 Objective:To explore the expression and effect of Fas and FasL in rat liver tumor promotion by phenobarbital(PB) Methods:The rat liver initiating-promoting model was established by DEN treatment(initiating)followed by a selection phase(2-AFF treatment and partial hepatectomy)and then by PB-promoting Immunohistochemistry was used to investigate the expression of Fas and FasL Results:It was shown that Fas exfression level in all initiated groups(high-dose,middle-dose,low-dose and initiating group)was higher than that in normal control group;however,FasL was not observed in normal group or promoting group but expressed in other groups After 15 weeks of administration of PB,Fas protein in high-dose and middle-dose group declined significantly while FasL protein increased remarkably Conclusion:The results suggested that down-regulation of Fas and up-regulation of FasL might participate in the tumor promotion of rat liver by PB,while its mechanism still remain unclarified
出处 《西南国防医药》 CAS 2003年第2期126-129,共4页 Medical Journal of National Defending Forces in Southwest China
基金 国家自然科学基金资助NO:39770 6 37
关键词 肝癌 促癌过程 FAS FASL 肝细胞 促癌物 大鼠 Fas,FasL,tumor promotion
  • 相关文献

参考文献12

  • 1Y Takeda T,Umeshita K,Sakca M,et al.Fas antigen expression in hepatocellular carcinoma tissue.Oncol Rep,1998;5:41~44
  • 2Higaki.K,Yano.H and Kojiro M.Fas antigen expression and relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissue.Am J Pathol,1996;149:429
  • 3Von Bernstorff W,Spanjaard RA,Chan AK,et al.Pancreatic cancer cells can evade immune surveillance via nonfunctional FAS(Apo-1/CD95)receptors and aberrant expression of vfunctional Fas ligand.Surgery,1999;125:73~84
  • 4Loro LL,Vintermyr OK,Johannessen AC,et al.Suppressin of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oralsquamous cell carcinome.J Oral Pathol Med,1999;28:82~87
  • 5Koomngi Rand Volm M.Expression of Fas(CD95/Apo-1)and Fas ligand in lung cancer,its prognostic and predictive relevance.Int J Cancer,1999;84:239~243
  • 6Anel A,Buferne M,Boyer C et al.T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A.Eur J Immunol,1994;24:2469~2476
  • 7Adachi M,Suematsu S,Kendo T,et al.Targeted mutation in the Fas gene cause hyperplasia in peripheral lymphoid organs and liver.Nature Genet,1995;11:294~300
  • 8Ogasawara J,Watanabe Fr,Adachi M,et al.Lethal effects of the anti-Fas antiboby in mice.Nature,1993;364:806
  • 9Galle PR,Hofmann WJ,Walczak H,et al.Involvement of the CD95(Apo-1/Fas)receptor an ligand in liver damage.J Exp Med,1995;182:1223~1230
  • 10Michael JP,Thomas B,Douglas RG,et al.Fas and Fas ligand I gut and liver.Am J Physiol Gastrointest Liver Physiol,2000:278:G354~G366

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部